Back
Arbutus Biopharma Stock Price Chart
Sponsored
ABUS
Sponsored
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
37
ABUS
Arbutus Biopharma
Last Price:
3.51
Seasonality Move:
24.22%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABUS is experiencing slight buying pressure.
Arbutus Biopharma Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.54 | Sell |
20-day SMA: | 3.74 | Sell |
50-day SMA: | 3.89 | Sell |
200-day SMA: | 3.38 | Buy |
8-day EMA: | 3.55 | Sell |
20-day EMA: | 3.69 | Sell |
50-day EMA: | 3.8 | Sell |
200-day EMA: | 3.43 | Buy |
Arbutus Biopharma Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.13 | Sell |
Relative Strength Index (14 RSI): | 34.97 | Sell |
Chaikin Money Flow: | 429896 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.59 - 4.01) | Sell |
Bollinger Bands (100): | (3.58 - 4.12) | Sell |
Arbutus Biopharma Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Arbutus Biopharma Stock
Is Arbutus Biopharma Stock a Buy?
- Arbutus Biopharma share price is 3.51 while ABUS 8-day simple moving average is 3.54, which is a Sell signal.
- The stock price of ABUS is 3.51 while Arbutus Biopharma 20-day SMA is 3.74, which makes it a Sell.
- Arbutus Biopharma 50-day simple moving average is 3.89 while ABUS share price is 3.51, making it a Sell technically.
- ABUS stock price is 3.51 and Arbutus Biopharma 200-day simple moving average is 3.38, creating a Buy signal.
ABUS Technical Analysis vs Fundamental Analysis
Sell
37
Arbutus Biopharma (ABUS)
is a Sell
Is Arbutus Biopharma a Buy or a Sell?
-
Arbutus Biopharma stock is rated a Sell
The current Arbutus Biopharma [ABUS] share price is $3.51. The Score for ABUS is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
Arbutus Biopharma Stock Info
Market Cap:
665.12M
Price in USD:
3.51
Share Volume:
716.49K
Arbutus Biopharma 52-Week Range
52-Week High:
4.73
52-Week Low:
1.79
Sell
37
Arbutus Biopharma (ABUS)
is a Sell
Arbutus Biopharma Share Price Forecast
-
What is the Arbutus Biopharma stock price today?
The Arbutus Biopharma stock price is 3.51 USD today. -
Will ABUS stock go up or go down?
Arbutus Biopharma> share price is forecast to RISE/FALL based on technical indicators -
Is Arbutus Biopharma overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Arbutus Biopharma is overvalued.
Is Arbutus Biopharma Stock a Buy?
- Arbutus Biopharma share price is 3.51 while ABUS 8-day exponential moving average is 3.55, which is a Sell signal.
- The stock price of ABUS is 3.51 while Arbutus Biopharma 20-day EMA is 3.69, which makes it a Sell.
- Arbutus Biopharma 50-day exponential moving average is 3.80 while ABUS share price is 3.51, making it a Sell technically.
- ABUS stock price is 3.51 and Arbutus Biopharma 200-day simple moving average is 3.43, creating a Buy signal.
Fundamental Analysis of Arbutus Biopharma
Is Arbutus Biopharma a good investment?
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.04 per share.
Technical Analysis of Arbutus Biopharma
Should I short Arbutus Biopharma stock?
- ABUS Moving Average Covergence Divergence (MACD) indicator is -0.13, suggesting Arbutus Biopharma is a Sell
- Arbutus Biopharma Relative Strength Index (RSI) is 34.97, which suggest Arbutus Biopharma is oversold
- The Bollinger Bands (25) for Arbutus Biopharma is (3.59 - 4.01), which suggest Arbutus Biopharma is a Sell
- The Bollinger Bands (100) for Arbutus Biopharma is (3.58 - 4.12), which suggest Arbutus Biopharma is a Sell
* Arbutus Biopharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.